Page last updated: 2024-08-25

isoalantolactone and Cancer of Head

isoalantolactone has been researched along with Cancer of Head in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, J; Li, C; Li, H; Li, L; Mei, X; Ren, F; Weng, Z; Wu, M; Zhang, H; Zhao, Y1
Fan, Y; Gao, H; Hu, J; Li, L; Liu, H; Wang, H; Weng, Z1

Other Studies

2 other study(ies) available for isoalantolactone and Cancer of Head

ArticleYear
Isoalantolactone inhibits UM-SCC-10A cell growth via cell cycle arrest and apoptosis induction.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclin D; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Head and Neck Neoplasms; Humans; Mitochondria; rho GTP-Binding Proteins; Sesquiterpenes; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53

2013
Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; G2 Phase; Head and Neck Neoplasms; Hep G2 Cells; Humans; MAP Kinase Signaling System; Phosphorylation; Radiation Tolerance; Radiation-Sensitizing Agents; Rats; Sesquiterpenes; Signal Transduction

2015